SCHEMBL4394629

SCHEMBL4394629

CCOC(=O)CNO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL939170 0.82
SCHEMBL23561304 0.81 GAA (0.65)
SCHEMBL391332 0.81 GAA (0.65)
Hydrochloric Acid SCHEMBL1061994 0.80 GAA (0.56)
Hydrochloric Acid SCHEMBL27917473 0.79 GAA (0.62)
SCHEMBL10382606 0.79
SCHEMBL28234269 0.79 GAA (0.62)
SCHEMBL179686 0.79
SCHEMBL3115421 0.79
SCHEMBL8345579 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022005468-A1 HYDROPHOBIC FLOW BARRIERS HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2022-01-06 WO disclosed
WO-2022005467-A1 HYDROPHOBIC FLOW BARRIERS HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2022-01-06 WO disclosed
EP-3490562-A1 IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY The Board of Trustees of the Leland Stanford Junior University (US) 2019-06-05 EP disclosed
EP-2516387-B1 INHIBITORS OF CYCLOPHILINS FOR USE IN THE PREVENTION AND/OR THE TREATMENT OF VIRAL PATHOLOGIES OR INFECTIONS INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE (INSERM) (FR) 2018-02-21 EP disclosed
WO-2018022930-A1 IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2018-02-01 WO disclosed
EP-1073767-B1 METHODS, KITS AND COMPOSITIONS FOR DETECTING AND QUANTITATING TARGET SEQUENCES BOSTON PROBES INC (US) 2009-11-25 EP disclosed
EP-1373359-A4 METAL-CONTAINING COMPOSITION AND PROCESS THEREWITH DU PONT (US) 2008-08-20 EP disclosed
EP-1373359-A1 METAL-CONTAINING COMPOSITION AND PROCESS THEREWITH E.I. DU PONT DE NEMOURS AND COMPANY (US) 2004-01-02 EP disclosed
WO-2002068497-A1 METAL-CONTAINING COMPOSITION AND PROCESS THEREWITH E.I. DU PONT DE NEMOURS AND COMPANY (US) 2002-09-06 WO disclosed
EP-0364517-B1 PREVENTION OF PROSTHESIS CALCIFICATION BIOMEDICAL DESIGN INC (US) 1994-04-06 EP disclosed
EP-0364517-A4 PREVENTION OF PROSTHESIS CALCIFICATION 1991-01-16 EP disclosed
US-4976733-A USING ALIPHATIC CARBOXYLIC ACID BIOMEDICAL DESIGN, INC. (US) 1990-12-11 US disclosed
EP-0364517-A1 PREVENTION OF PROSTHESIS CALCIFICATION. BIOMEDICAL DESIGN INC (US) 1990-04-25 EP disclosed
WO-1989006945-A1 PREVENTION OF PROSTHESIS CALCIFICATION BIOMEDICAL DESIGN, INC. (US) 1989-08-10 WO disclosed